Rhodiola: Fatigue, Stress and Focus
Rhodiola rosea is an Arctic root sold for stress and mental fatigue. A handful of small trials of one Swedish extract carry most of the evidence, and many jars on the market contain a different plant.

Build your own printable peptide tracker
A personalized injection log, weekly dosing schedule and dated calendar: your compounds filled in, ready to print. Free to build and preview; $5/month to unlock printing.
What Is Rhodiola and How Might It Work?
Rhodiola rosea, also called golden root or arctic root, is registered in the UK as a traditional herbal medicine for stress-induced fatigue, exhaustion and anxiety. Rosavin is the marker that separates it from related Rhodiola species, while salidroside also occurs in other species (Rhodiola product authenticity study, PMID 26626192). About 140 compounds have been isolated from the root and rhizome (rosenroot review, PMID 20378318).
In the stress-related fatigue trial, the change in salivary cortisol response to awakening differed between the SHR-5 group and the placebo group after 28 days (stress-related fatigue RCT, PMID 19016404). A 2010 review lists proposed links to stress-system proteins such as Hsp70, drawn from cell and animal work (rosenroot review, PMID 20378318).
In a human neuroglia cell line, SHR-5 extract changed the expression of 1,062 genes, and salidroside, triandrin and tyrosol each changed a similar number. The authors concluded that several compounds contribute to the effect, not one active ingredient (neuroglial cell gene study, PMID 25172797). This is test-tube work.
In 28 healthy volunteers, a single 500 mg dose of rhodiola extract prevented the long-term-depression-like drop in motor responses that cathodal brain stimulation normally causes, and did not change cortical excitability (human neuroplasticity study, PMID 30477830).
What the Data Shows
Daily Dosing Schedule
Key Takeaways
- In 60 adults with stress-related fatigue, 576 mg a day of SHR-5 for 28 days beat placebo on a burnout scale and on several attention measures, though both groups improved (PMID 19016404).
- In 161 cadets doing mental work under fatigue, a single dose of SHR-5 raised an anti-fatigue index to 1.0385 vs 0.9046 on placebo, and a 50% higher dose was no better (PMID 12725561).
- Night-duty physicians (56) scored better on mental-fatigue tests on low-dose SHR-5 than on placebo, though only in the first two-week period of a crossover (PMID 11081987), and students during exams improved on mental fatigue and physical fitness vs placebo (PMID 10839209).
- A 2011 systematic review found 11 placebo-controlled trials, most of moderate or good quality, with only a few mild adverse events reported (PMID 21036578).
- In the sertraline comparison trial, 30.0% of people on rhodiola reported adverse events vs 63.2% on sertraline (PMID 25837277).
- Product quality varies widely: about one fifth of products sold as Rhodiola rosea contained no rosavin (PMID 26626192), and labelled salidroside and rosavin amounts were confirmed in fewer than a quarter of products in a second analysis (PMID 32311178).
- Whether the fatigue results replicate. A 2012 review rated every included trial at high or unclear risk of bias (PMID 22643043), and a 2011 review pointed to a lack of independent replications (PMID 21036578).
- Whether rhodiola treats depression. A 6-week SHR-5 trial reported gains at 340 and 680 mg (PMID 17990195), but in a 12-week trial against sertraline rhodiola did not differ from placebo (PMID 25837277).
- Whether the stress and burnout gains are a drug effect. The WS 1375 studies were single-arm and open-label (PMID 22228617, PMID 28219059, PMID 28367055), one with a co-author listing a Dr Willmar Schwabe affiliation (PMID 28367055), and the anxiety trial used a no-treatment control (PMID 26502953).
- Whether it sharpens thinking in healthy people. The anxiety trial found no relevant difference in cognitive tests (PMID 26502953); a 2025 trial in lifters reported Stroop gains measured against a no-capsule condition (PMID 41374026).
- Whether it helps endurance. Two meta-analyses disagree on VO2max (PMID 41080184, PMID 42908635), and the 2026 analysis found no protection against acute mountain sickness (PMID 42908635).
- How it interacts with medicines. Six commercial products inhibited the drug-metabolizing enzyme CYP3A4 in the test tube (PMID 27572116), while purified salidroside showed no interaction risk in a lab study whose authors hold stock in its maker (PMID 37686755). The trials cited here ran 12 weeks at most (PMID 25837277, PMID 28367055).
Frequently Asked Questions
Does rhodiola help with focus or mental fatigue?
Under stress or fatigue, several small trials say yes. SHR-5 beat placebo on attention measures in people with stress-related fatigue (stress-related fatigue trial, PMID 19016404) and on an anti-fatigue index in cadets (cadet trial, PMID 12725561), and night-duty physicians did better on mental-fatigue tests during the first two-week period of a crossover trial (night-duty physicians trial, PMID 11081987). In mildly anxious adults it made no difference to cognitive tests (anxiety trial, PMID 26502953).
Does rhodiola help with stress and anxiety?
The supporting studies lack a placebo arm. In 80 mildly anxious adults, 200 mg twice daily for 14 days reduced self-reported anxiety, stress and anger compared with no treatment (Vitano anxiety trial, PMID 26502953). In 101 adults with life-stress symptoms, 200 mg twice daily improved stress scores within 3 days in a single-arm study (WS 1375 life-stress study, PMID 22228617).
Is rhodiola an antidepressant?
The evidence conflicts. In 89 patients with mild to moderate depression, 340 or 680 mg a day of SHR-5 for 6 weeks improved depression scores while placebo did not (SHR-5 depression trial, PMID 17990195). In a 12-week US trial, rhodiola cut depression scores by 5.1 points vs 4.6 on placebo and 8.2 on sertraline, with no significant differences between groups (rhodiola vs sertraline trial, PMID 25837277).
How much rhodiola do studies use?
Most trials used 340 to 680 mg a day of an extract. The burnout trial gave 576 mg of SHR-5 daily for 28 days (PMID 19016404), the depression trial 340 or 680 mg (PMID 17990195), and the WS 1375 studies 200 mg twice a day (PMID 22228617, PMID 28219059). A 2025 meta-analysis of endurance trials saw larger VO2max gains above 600 mg a day (endurance meta-analysis, PMID 41080184).
How do I know a rhodiola product is real?
Check the label for rosavin, not only salidroside. In about 40 products tested in the UK, roughly one fifth labelled Rhodiola rosea had no rosavin, the marker of the true species, and many others appeared to contain other Rhodiola species (Rhodiola product authenticity study, PMID 26626192). Of six commercial products tested in Norway, one contained no rosavin, rosarin or rosin at all (commercial product CYP study, PMID 27572116).
Does rhodiola interact with medications?
Possibly. Commercial rhodiola products inhibited CYP3A4, CYP2D6 and CYP1A2, liver enzymes that clear many drugs, in test-tube work, and the authors note one product had already been shown to inhibit these enzymes in people (commercial product CYP study, PMID 27572116). Ask a pharmacist or clinician before combining it with prescription medicines.
Recommended Products
Support supplements and gear relevant to this protocol.
Affiliate links support HighPeptides at no extra cost.
Related HighPeptides Research
Peer-Reviewed References
67-page guide: protocols, dosing, sourcing. Everything in one place.
Get the guide: $19 (normally $29) → The Peptide Buyer’s Playbook ($19) All ebooks & guides →Educational purposes only. Not medical advice.
Rhodiola is sold in the US as a dietary supplement, not an FDA-approved drug. Talk to a clinician before using it if you are pregnant, take prescription medicines, or are being treated for any condition.
Get the Free 2026 Peptide Protocol Stack
Twelve compounds across four pillars: metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.